Changes are happening - please bear with us while we update our site.

Changes are happening - please bear with us while we update our site.

Why the Ramsay (ASX:RHC) share price could shoot higher today

The Ramsay Health Care Limited (ASX:RHC) share price could be one of the risers today after receiving a takeover offer.

The Ramsay Health Care Limited (ASX: RHC) share price could be one of the leaders today after receiving a takeover offer.

Ramsay is one of the largest private hospital operators. But one day, it may not be on the ASX.

Takeover offer for Ramsay

According to the Australian Financial Review reporting, the private hospital business has received an indicative, non-binding bid to buy the company for more than $20 billion. So, I wouldn’t be surprised to see the Ramsay share price rise today.

According to the ASX, Ramsay Health Care has a market capitalisation of $14.8 billion according to the ASX, so this offer seems quite hefty if it turns into a real bid that can be accepted.

The indicative bid has come from the private equity group KKR (Kohlberg Kravis Roberts & Co).

At this stage, Ramsay Health Care is giving KKR due diligence material so that it can hopefully progress with a more official bid.

According to the Australian Financial Review’s Street Talk, the offer is all-cash, though there is apparently an option for some shareholders to potentially “roll” their stages into the deal.

The largest holder of Ramsay Health Care shares, Paul Ramsay’s Ramsay Foundation, is reportedly supportive of the takeover talks that are happening.

How well are things going?

The recent FY22 half-year result showed ongoing difficulties for the business. While total revenue rose 1.2% to $6.69 billion, the EBIT (EBIT explained) fell 16.2% to $489.2 million, profit before tax dropped 23.8% to $303.7 million and statutory net profit after tax (NPAT) declined 29.7%. The lack of net profit growth has probably been a key factor for the Ramsay share price.

It noted that this result was severely impacted by the disruption from new waves of COVID-19. The negative impact from COVID-19 on the Australian business during the period is estimated to have been $107 million.

Volumes are expected to increase as restrictions ease. though costs remain elevated.

The business is expected to benefit from the additional volume created by the backlog of elective surgery and non-surgical services both in the public and private sector as COVID cases in the community decline.

It recently made a UK acquisition.

Final thoughts on the Ramsay share price

It’s interesting that a bid has come in, it seems like a pretty good one (which could be raised). I’d be happy if I were a shareholder.

There are plenty of ASX growth shares I’d happily put the money towards.

$50,000 per year in passive income from shares? Yes, please!

With interest rates UP, now could be one of the best times to start earning passive income from a portfolio. Imagine earning 4%, 5% — or more — in dividend passive income from the best shares, LICs, or ETFs… it’s like magic.

So how do the best investors do it?

Chief Investment Officer Owen Rask has just released his brand new passive income report. Owen has outlined 10 of his favourite ETFs and shares to watch, his rules for passive income investing, why he would buy ETFs before LICs and more.

You can INSTANTLY access Owen’s report for FREE by CLICKING HERE NOW and creating a 100% FREE Rask Account.

(Psst. By creating a free Rask account, you’ll also get access to 15+ online courses, 1,000+ podcasts, invites to events, a weekly value investing newsletter and more!)

Unsubscribe anytime. Read our TermsFinancial Services GuidePrivacy Policy. We’ll never sell your email address. Our company is Australian owned.

Information warning: The information on this website is published by The Rask Group Pty Ltd (ABN: 36 622 810 995) is limited to factual information or (at most) general financial advice only. That means, the information and advice does not take into account your objectives, financial situation or needs. It is not specific to you, your needs, goals or objectives. Because of that, you should consider if the advice is appropriate to you and your needs, before acting on the information. If you don’t know what your needs are, you should consult a trusted and licensed financial adviser who can provide you with personal financial product advice. In addition, you should obtain and read the product disclosure statement (PDS) before making a decision to acquire a financial product. Please read our Terms and Conditions and Financial Services Guide before using this website. The Rask Group Pty Ltd is a Corporate Authorised Representative (#1280930) of AFSL #383169.

At the time of publishing, Jaz does not have a financial or commercial interest in any of the companies mentioned.
Skip to content